D-DIMER AND ANNEXIN A2 LEVELS IN PREGNANT WOMEN WITH POST-COVID SYNDROME
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
It is established that only approximately 5% of SARS-CoV-2 infections progress to a severe course, a phenomenon largely attributable to underlying comorbidities. The mechanisms underlying complications of coronavirus infection in pregnant women remain relevant and incompletely elucidated. The aim of study was to determine plasma levels of D-dimer and annexin A2 in pregnant women with post-COVID syndrome. Methods and materials. The study enrolled 60 pregnant women (main group) with confirmed prior SARS-CoV-2 infection, as evidenced by positive IgA, IgM, or IgG antibodies to SARS-CoV-2. The control group comprised 25 women with physiological pregnancies. Participants were stratified into clinical subgroups as follows: Group 1 included 10 patients with SARS-CoV-2 infection during the first trimester; Group 2 included 25 pregnant women with SARS-CoV-2 infection during the second trimester; and Group 3 included 25 pregnant women with SARS-CoV-2 infection during the third trimester. Plasma annexin A2 and D-dimer levels were measured using a Coag Chrom 3003 analyzer. Statistical analysis was performed with the Statistica 10 software package for Windows. The study protocol was approved by the Ethics Committee of I. Ya. Horbachevsky Ternopil National Medical University (protocol No. 61, dated 13 November 2020). The investigation was conducted as part of the research project entitled “Improving diagnostics and treatment of pregnant women with a burdened somatic history” (Department of Obstetrics and Gynecology, Faculty of Postgraduate Education, I. Ya. Horbachevsky Ternopil National Medical University, state registration No. 0121U100153, implementation period 2021–2023) and the research project entitled “Reproductive function of women and the course of pregnancy in conditions of modern stress factors” (Department of Obstetrics and Gynecology, Faculty of Postgraduate Education, I. Ya. Horbachevsky Ternopil National Medical University, state registration No. 0124U000054, implementation period 2024–2026). Results of the study and their discussion. Plasma annexin A2 and D-dimer levels were assessed in the control group and in pregnant women with confirmed SARS-CoV-2 infection across the first, second, and third trimesters. In Groups 1 and 2, annexin A2 levels did not differ significantly from each other (P2 > 0.05). In Group 3 (pregnant women with SARS-CoV-2 infection during the third trimester and the shortest duration of post-COVID syndrome, where disease severity necessitated inpatient treatment), the mean annexin A2 level was 21.45 ± 1.31 ng/ml, which was significantly different from the control group, Group 1, and Group 2 (P1 < 0.001, P2 < 0.05, P3 < 0.05). Analysis of D-dimer levels revealed that values in Groups 2 and 3 differed significantly from those in the control group and Group 1, respectively (P1 < 0.001, P2 < 0.001), whereas no significant difference was observed between Groups 2 and 3 (P3 > 0.05). Conclusions. Hypercoagulable syndrome represents one of the key mechanisms underlying complications of coronavirus infection in pregnant women and constitutes a major pathogenetic indicator of an unfavorable prognosis in patients with SARS-CoV-2 infection. Consequently, administration of low-molecular-weight heparins in pregnant women with post-COVID syndrome is a pathogenetically justified approach to the prevention of thrombotic complications.
Fields of Study & Subjects
COVID-19 Impact on Reproduction
COVID-19 Clinical Research Studies
Long-Term Effects of COVID-19
Publication details
- Journal / source
- Neonatology surgery and perinatal medicine
- Volume
- 16
- Issue
- 1(59)
- Pages
- 99–103
- Publication date
- 27 March 2026
- Language
- EN